Justin D. Gover, Chief Executive Officer at GW PHARMACEUTICALS PLC (GWPH), sold 202,224 shares at $15.08 ($3.1M) on 2019-05-28, disclosed to the SEC on 2019-05-30.
Open-market sale of $3.1M GWPH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.08 | 52,680 | $794K | 25.8% |
| 2 | $15.17 | 26,784 | $406K | 13.2% |
| 3 | $15.25 | 56,736 | $865K | 28.1% |
| 4 | $15.35 | 40,728 | $625K | 20.3% |
| 5 | $15.43 | 19,284 | $298K | 9.7% |
| 6 | $15.49 | 6,012 |
| $93K |
| 3.0% |
| Total | $15.24 avg | 202,224 | $3.1M | 100% |
| Filing → |
| GWPH | SELL | 2020-03-04 | $477K | — | Filing → |
| GWPH | SELL | 2020-02-28 | $194K | — | Filing → |
| GWPH | SELL | 2020-02-05 | $3.9M | — | Filing → |